Janssen Search
Search results
Jörg
"I have a natural affinity to collaboration, communication, and knowledge management principles, especially in the context of making innovation and communities sustainable. At Janssen, the ability to collaborate as a team, utilize innovation and ...
Anne Fourie, Ph.D.
Anne Fourie, Ph.D., has held several positions of increasing responsibility during her more than 20-year career at the Janssen Pharmaceutical Companies of Johnson & Johnson. In her current role, Anne is responsible for driving the strategic direction ...
Our Products
Article Type: Infectious Diseases & Vaccines Our Products Our expanding infectious diseases pipeline is comprised of transformational medical innovations. These therapies and vaccines are redefining viral infections like human immunodeficiency virus ...
Toon Overstijns
Toon Overstijns is the Global Commercial Strategy Leader for the Infectious Diseases & Vaccines Therapeutic Area. Toon started his career in Janssen as Area Managing Director for Janssen Central and Eastern Europe. He later served for five years as ...
Precision Medicine and Co-Diagnostics
About the Precision Medicine Model Partners in Precision Medicine Precision Medicine Glossary About the Precision Medicine Model Partner with Us We are committed to partnering with those whose innovative thinking will bring new and creative solutions to ...
Focused on Hepatitis C Treatment & Prevention
Article Type: Infectious Diseases & Vaccines Hepatitis B Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It is, like hepatitis C (HCV), a major global health problem and significant burden on those ...
Partner with the Janssen Prevention Center
Article Type: Disease Interception Accelerator Partner with the Janssen Prevention Center The Janssen Prevention Center (JPC) is a research group within Janssen. Launched at the start of 2015, the center will explore new approaches to disease prevention ...
Presbyopia and Cataracts
Article Block Text: Intercepting the progression of presbyopia and cataracts. Article Type: Disease Interception Accelerator Presbyopia and Cataracts Working to develop topical solutions (eye drops) that will intercept presbyopia and cataracts and ...
Chronic Obstructive Pulmonary Disease
Article Block Text: Tracking risk and early stages of the disease to stop airway destruction. Article Type: Disease Interception Accelerator Chronic Obstructive Pulmonary Disease Pinpointing individuals at risk and in the earliest stages of chronic ...
Global Public Health
Global Public Health Global Public Health Nelly Velez, The World Among Us About Our Global Public Health Initiative Global Public Health Research Increasing Sustainable Access to Medicines Our Partnerships Fighting Multi-Drug Resistant Tuberculosis ...